Granite Investment Partners, LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1542266
EL SEGUNDO, CA
Position in ADPT
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$6,940,846
+$6,790,199 QoQ
Shares Held
500,061
+4865.8% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Granite Investment Partners, LLC holds $43,990,923 across 8 Diagnostics & Research names. ADPT ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCYT |
Veracyte, Inc.
|
298,589 | $9,617,551 | |
| 2 | GH |
Guardant Health, Inc.
|
95,726 | $8,842,210 | |
| 3 | ADPT |
Adaptive Biotechnologies Corp
This page
|
500,061 | $6,940,846 | |
| 4 | NEO |
Neogenomics Inc
|
752,478 | $5,583,386 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
11,098 | $5,454,999 | |
| 6 | DHR |
Danaher Corp /De/
|
26,604 | $5,044,118 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
3,718 | $2,089,107 | |
| 8 | WAT |
Waters Corp /De/
|
1,406 | $418,706 |
All Filings in ADPT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,940,846 | 500,061 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $150,647 | 10,070 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $116,569 | 10,006 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $85,066 | 11,449 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||